KLOW
Also known as: KLOW Blend, GLOW + KPV, KPV/BPC-157/TB-500/GHK-Cu Blend, BPC-157/TB-500/GHK-Cu/KPV Blend
KLOW is a market blend built around KPV, GHK-Cu, BPC-157, and TB-500. ProtoComp treats it as a broad repair stack with an added anti-inflammatory layer: KPV covers melanocortin-fragment inflammation context, GHK-Cu covers copper-linked tissue remodeling and skin-aging context, and BPC-157/TB-500 cover complementary repair-pathway context. The blend itself should not be treated as a single studied molecule.
No dose range recorded.
No cycle range recorded.
Blend entry only. Interpret timing, route, and risk from the component entries.
Common side effects
- • Injection site irritation
- • Component-specific effects vary by formulation
Serious risks
- • Blend-specific human outcome data are not established
Drug interactions
- • May duplicate KPV, BPC-157, TB-500, or GHK-Cu if those are also logged separately
Requires monitoring
- • Review each component before stacking with separate repair peptides
Pregnancy / breastfeeding
No data - consult clinician
- KLOW is a blend label, not a single peptide molecule.
- Adding KPV changes the inflammation/gut-immune profile, but blend-specific human outcome data are not established.
- Avoid double-counting if KPV, BPC-157, TB-500, or GHK-Cu are also in the stack as separate items.
Sign in to calculate your dose, add this compound to your stack, and check for interactions with your current cabinet.